Are there specific Cannabis’ CBD-to-THC ratios recommended for PMR?

PostedFebruary 23, 2026

UpdatedFebruary 23, 2026

ByMy Patient Advice

Author: Julia Sutton, MSc | Reviewed by: Dr. Clarissa Morton, PharmD

When exploring cannabis treatment for polymyalgia rheumatica , many patients wonder about the ideal CBD to THC ratio for PMR. The ratio of these cannabinoids can significantly influence pain relief, inflammation control, and side effect management. Understanding how to balance CBD and THC helps tailor treatment to individual needs.

Importance of Ratio Selection

The right CBD to THC ratio for PMR varies between patients, depending on sensitivity, tolerance, and specific symptoms. While there is no universal recommendation, certain patterns have emerged in clinical and patient experiences.

Cannabinoid Balance

Achieving proper cannabinoid balance is key to effective therapy. Higher CBD content often reduces the psychoactive effects of THC while supporting anti-inflammatory benefits. Ratios like 20:1 or 10:1 (CBD to THC) are often considered gentler starting points.

Personalised Dosing

Personalised dosing allows patients to adjust ratios over time. Some may prefer higher THC content for stronger pain control, while others may respond better to CBD-dominant formulations. Careful titration is essential to minimise unwanted effects.

Targeted Symptom Relief

Adjusting the CBD to THC ratio for PMR enables targeted symptom relief. For instance, daytime use may require more CBD for focus and function, while evening doses with slightly more THC may promote relaxation and sleep.

The best CBD to THC ratio for PMR is highly individual and often requires experimentation. By focusing on cannabinoid balance, exploring personalised dosing, and aiming for targeted symptom relief, patients can find the most effective approach to managing their PMR symptoms. Consulting a knowledgeable healthcare provider ensures safe and guided adjustments.

If you’re exploring cannabis treatment options for polymyalgia rheumatica, visit providers like LeafEase for personalised consultations and guidance tailored to your needs.

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Medical Cannabis and polymyalgia rheumatica.

Julia Sutton, MSc

Author

Julia Sutton is a clinical psychologist with a Master’s in Clinical Psychology and experience providing psychological assessment and therapy to adolescents and adults. Skilled in CBT, client-centered therapy, and evidence-based interventions, she has worked with conditions including depression, anxiety, bipolar disorder, and conversion disorder. She also has experience in child psychology, conducting psycho-educational evaluations and developing tailored treatment plans to improve learning and well-being.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy.

Dr. Clarissa Morton, PharmD

Reviewer

Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the reviewers's privacy.